1996
DOI: 10.1016/0378-5955(96)00105-0
|View full text |Cite
|
Sign up to set email alerts
|

Na,K-ATPase α- and β-isoforms in the developing cochlea of the mouse

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
39
0
2

Year Published

2001
2001
2008
2008

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 56 publications
(43 citation statements)
references
References 20 publications
2
39
0
2
Order By: Relevance
“…Thus, there does not seem to be a particular subcellular compartment to which NKAα3 expression is restricted in either the central or peripheral nervous system. Our findings are consistent with earlier research using immunocytochemistry that identified the NKAα3 in the SGNs and cochlear nerve in the gerbil (Schulte and Adams 1989;McGuirt and Schulte 1994;Nakazawa et al 1995), rat (ten Cate et al 1994;Peters et al 2001), and mouse (Erichsen et al 1996). NKAα immunoreactivity was localized to the nerve terminals underlying the IHCs and OHCs in the human cochlea (Weber et al 2001).…”
Section: Discussionsupporting
confidence: 92%
See 3 more Smart Citations
“…Thus, there does not seem to be a particular subcellular compartment to which NKAα3 expression is restricted in either the central or peripheral nervous system. Our findings are consistent with earlier research using immunocytochemistry that identified the NKAα3 in the SGNs and cochlear nerve in the gerbil (Schulte and Adams 1989;McGuirt and Schulte 1994;Nakazawa et al 1995), rat (ten Cate et al 1994;Peters et al 2001), and mouse (Erichsen et al 1996). NKAα immunoreactivity was localized to the nerve terminals underlying the IHCs and OHCs in the human cochlea (Weber et al 2001).…”
Section: Discussionsupporting
confidence: 92%
“…We found no NKAα1 immunoreactivity in the afferent terminals. Previous studies have reported weak to moderate NKAα1 immunoreactivity in the SGNs and cochlear nerve of the rat (ten Cate et al 1994;Peters et al 2001;Delprat et al 2007) and mouse (Erichsen et al 1996), and one study reports expression of the NKAα in the afferent terminals underlying the OHCs in the gerbil (Nakazawa et al 1995). Although we did not find NKAα1 immunoreactivity in either type I or II afferent terminals, we did see NKAα1 labeling in the spiral ganglion (data not shown) but were unable to identify unequivocally the NKAα1-expressing cells as either the SGNs or ensheathing satellite cells.…”
Section: Discussionmentioning
confidence: 92%
See 2 more Smart Citations
“…The rationale for the current study comes from the finding that the cochlea contains a number of proteins known to interact with NHERFs, plus numerous other proteins that have PDZ domains that could potentially interact with NHERFs. These cochlear proteins include NHE3 (Bond et al 1998), the ERM family (Kitajiri et al 2004), actin (Geal-Dor et al 1993;Nishida et al 1998), myosin (Boeda et al 2002;Johnson et al 2003;Mburu et al 2003;Kitajiri et al 2004;Belyantseva et al 2005;Kikkawa et al 2005), NBC3 (Bok et al 2003), P2Y1 (Teixeira et al 2000), β-adrenergic receptors (Fauser et al 2004), the vacuolar proton pump v-H + -ATPase (Stankovic et al 1997), Na + -K + ATPase (Ichimiya et al 1994;Erichsen et al 1996), growth factor receptors (Pickles and van Heumen 1997), glucocorticoid receptors (Erichsen et al 1996), TASK-1 background K + channels (Kanjhan et al 2004a), inwardly rectifying K + channels Kir1.1 (ROMK1) (Glowatzki et al 1995), Kir4.1 and Kir5.1 (Hibino et al 2004), aquaporin-4 (Mhatre et al 2002), glutamate transporter GLAST (Furness and Lehre 1997), and plasma membrane Ca 2+ -ATPase (Ichimiya et al 1994;Dumont et al 2001). …”
Section: Discussionmentioning
confidence: 99%